Loading...
XHEL
NXTMH
Market cap64mUSD
Apr 28, Last price  
7.90EUR
1D
-0.25%
1Q
0.00%
Jan 2017
-49.13%
IPO
-98.70%
Name

Nexstim Oyj

Chart & Performance

D1W1MN
P/E
—
P/S
6.50
EPS
—
Div Yield, %
—
Shrs. gr., 5y
36.04%
Rev. gr., 5y
21.14%
Revenues
9m
+20.55%
3,190,4281,871,0272,210,4372,527,8702,482,6002,645,3482,672,1513,348,0864,113,9596,397,5169,526,6967,246,2848,735,367
Net income
0k
P
00000000001,306,824-1,327,5160
CFO
2m
P
-3,075,500-3,983,700-7,785,200-9,608,600-7,225,300-5,402,900-6,192,500-6,681,500-2,724,70001,002,177-2,268,9651,881,002

Profile

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.
URL
https://www.nexstim.com/
IPO date
Nov 14, 2014
Employees
37
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,735
20.55%
7,246
-23.94%
9,527
48.91%
Cost of revenue
2,635
8,451
2,041
Unusual Expense (Income)
NOPBT
6,101
(1,204)
7,486
NOPBT Margin
69.84%
78.58%
Operating Taxes
5
Tax Rate
NOPAT
6,101
(1,209)
7,486
Net income
(1,328)
-201.58%
1,307
 
Dividends
Dividend yield
Proceeds from repurchase of equity
1,815
82
43
BB yield
Debt
Debt current
1,123
832
878
Long-term debt
4,240
3,604
2,611
Deferred revenue
Other long-term liabilities
Net debt
1,498
2,304
(1,632)
Cash flow
Cash from operating activities
1,881
(2,269)
1,002
CAPEX
(1,489)
Cash from investing activities
(1,735)
Cash from financing activities
2,486
1,028
FCF
7,929
(1,174)
5,669
Balance
Cash
3,864
1,455
4,441
Long term investments
677
681
Excess cash
3,428
1,769
4,645
Stockholders' equity
80
2,836
55,040
Invested Capital
8,983
5,503
2,913
ROIC
84.23%
319.93%
ROCE
67.32%
99.04%
EV
Common stock shares outstanding
6,766
6,638
7,276
Price
Market cap
EV
EBITDA
6,958
(537)
7,983
EV/EBITDA
Interest
486
145
55
Interest/NOPBT
7.97%
0.73%